Dr Michelle Li
@michelle-li.bsky.social
Medical Oncologist & Breast Cancer Clinical Trials Fellow @ Peter Mac ➡️ Dana-Farber 2025. 🌈 #MedSky #OncSky #BCSM #WomenInMedicine
The landscape of personalised medicine in the HR+ MBC space is constantly changing. Great summary at #ESMOAsia of how we incorporate biomarkers into our treatment sequencing.
December 7, 2024 at 1:40 AM
The landscape of personalised medicine in the HR+ MBC space is constantly changing. Great summary at #ESMOAsia of how we incorporate biomarkers into our treatment sequencing.
Kicking off #ESMOAsia with a great session on precision medicine.
So many potential benefits of oral over IV PD-L1 agents… most of all economic costs + patient QoL. Could this be the future?
So many potential benefits of oral over IV PD-L1 agents… most of all economic costs + patient QoL. Could this be the future?
December 6, 2024 at 3:35 AM
Kicking off #ESMOAsia with a great session on precision medicine.
So many potential benefits of oral over IV PD-L1 agents… most of all economic costs + patient QoL. Could this be the future?
So many potential benefits of oral over IV PD-L1 agents… most of all economic costs + patient QoL. Could this be the future?